Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators

L.A. McKeown

August 21, 2019

News Daily News

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

Todd Neale

August 20, 2019

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Conference News ESC Heart Failure 2019

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Shelley Wood

May 28, 2019

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Shelley Wood

May 26, 2019

News Daily News

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

L.A. McKeown

May 13, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Conference News CRT 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Yael L. Maxwell

March 03, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Conference News ISC 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

Todd Neale

February 14, 2019

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

Todd Neale

January 29, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators

DAPA-HF: Dapagliflozin Scores a Win in Heart Failure

preCARDIA Enrolls First Patient in Early Feasibility Study

Weaning Off Diuretics in Stable Heart Failure? ReBIC-1 Hints at Possibilities

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Risk Prediction Tool Shows Promise for Detecting Heart Failure Earlier

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Mortality From Heart Failure Increasing in United States

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

TCTMD’s Top 10 Most Popular Stories for December 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content